• Have a question?
    Open from 8am to 7pm Monday to Friday
    Call customer services
    0345 54 32 600

Janus Henderson Glb Life Scn H1 GBP

Price: £44.14|Change: 0.40 (-0.90%)

Pricing frequency 

Daily


Dealing cut off time 

17:00


Type 

OEIC


Yield 

0.04%


NAV 

£44.14


Income frequency 

Annually


Ongoing charge 

0.86%


Latest actual NAV date 

16-11-2026


ISIN 

IE00BRJ9D748


UCITS 

Yes


Growth of 10k

Asset allocation

Top 10 holdings

Holdings 30/09/2026% of assets
Eli Lilly and Co9.61
Johnson & Johnson7.78
AbbVie Inc4.93
UnitedHealth Group Inc4.27
AstraZeneca PLC3.71
Thermo Fisher Scientific Inc3.35
Novartis AG ADR2.73
Roche Holding AG2.68
argenx SE ADR2.45
Merck & Co Inc2.35

Performance 31/10/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Fund- 0.90
Category-
More...

Investment objective

The Fund’s investment objective is long-term growth of capital. It pursues its objective by investing at least 80% of its net asset value in equities (also known as company shares) located anywhere in the world and selected for their growth potential. The Fund will invest at least 80% of its net asset value in companies that the relevant Sub-Investment Adviser believes have a life sciences orientation. Generally speaking, the “life sciences” relate to maintaining or improving quality of life. Thus, companies with a “life sciences orientation” include companies engaged in research, development, production or distribution of products or services related to health and personal care, medicine or pharmaceuticals. Such companies may also include companies that the relevant Sub-Investment Adviser believes have growth potential mainly as a result of particular products, technology, patents or other market advantages in the life sciences.

Sustainability Label

This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.


Morningstar ratingTM


Morningstar sustainability ratingTM


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.